<code id='4DF9B86400'></code><style id='4DF9B86400'></style>
    • <acronym id='4DF9B86400'></acronym>
      <center id='4DF9B86400'><center id='4DF9B86400'><tfoot id='4DF9B86400'></tfoot></center><abbr id='4DF9B86400'><dir id='4DF9B86400'><tfoot id='4DF9B86400'></tfoot><noframes id='4DF9B86400'>

    • <optgroup id='4DF9B86400'><strike id='4DF9B86400'><sup id='4DF9B86400'></sup></strike><code id='4DF9B86400'></code></optgroup>
        1. <b id='4DF9B86400'><label id='4DF9B86400'><select id='4DF9B86400'><dt id='4DF9B86400'><span id='4DF9B86400'></span></dt></select></label></b><u id='4DF9B86400'></u>
          <i id='4DF9B86400'><strike id='4DF9B86400'><tt id='4DF9B86400'><pre id='4DF9B86400'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:18977
          The Amgen booth at ESMO in Madrid.
          The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

          MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

          The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

          advertisement

          “It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Bacterial infection may be ‘key event’ in endometriosis, study says
          Bacterial infection may be ‘key event’ in endometriosis, study says

          AnewstudydocumentshowFusobacteriummightspurthedevelopmentofendometriosis.V.R.Dowell/CDCEndometriosis

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Obesity drugs seen as possible treatment for liver disease MASH

          AdobeAsdrugmakersracetojointheobesitydrugmarketignitedbytheapprovalofWegovyandZepbound,they’renotjus